Search

everythinglearnresearchcommunity

for

Search:↓

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Early recognition and aggressive treatment can significantly improve rare ANA-negative lupus with heart and skin issues.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Tph cells are linked to the severity of systemic lupus erythematosus.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Digital gangrene can be an initial symptom of late-onset systemic lupus erythematosus.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

Oral cyclosporin doesn't stop hair loss.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Digital gangrene can be a rare first sign of late-onset systemic lupus erythematosus.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.